Richardson Electronics sells majority of Richardson Healthcare to DirectMed
Richardson Electronics (RELL) announced the strategic asset sale of a majority of Richardson Healthcare to DirectMed Imaging. The transaction ...
Stocks to Watch: Richardson Electronics, Tevogen Bio Holdings
Tevogen Bio Holdings expanded its artificial-intelligence partnership with Microsoft. The immunotherapy biotech company said its AI effort, Tevogen.AI, will integrate Microsoft's advanced AI tools and ...
Richardson Electronics, Ltd. (RELL): A Bull Case Theory
We came across a bullish thesis on Richardson Electronics, Ltd. (RELL) on Substack by Shareholdersunite Essentials. In this ...
Ritholtz Wealth Management Purchases New Position in Richardson Electronics, Ltd. (NASDAQ:RELL)
Ritholtz Wealth Management acquired a new position in Richardson Electronics, Ltd. (NASDAQ:RELL – Free Report) during the 4th ...
Hosted on MSN17d
Richardson Electronics, Ltd. (NASDAQ:RELL) Q2 2025 Earnings Call Transcript
Richardson Electronics, Ltd. (NASDAQ:RELL) Q2 2025 Earnings Call Transcript January 8, 2025 Operator: Good day, and thank you for standing by. Welcome to Richardson Electronics Earnings Call ...
Richardson Electronics, Ltd.: Richardson Electronics Announces Strategic Transaction for its Richardson Healthcare Business Unit
Majority of Richardson Healthcare Assets Sold to DirectMed Imaging Remaining Healthcare Business to be Consolidated into the Company's PMT Strategic Business Unit LAFOX, Ill., Jan. 24, 2025 (GLOBE NEW ...
Richardson Electronics, Ltd. (NASDAQ:RELL) Shares Bought by Barclays PLC
Barclays PLC grew its holdings in Richardson Electronics, Ltd. (NASDAQ:RELL – Free Report) by 151.0% in the 3rd quarter, ...
Yahoo Finance13d
Richardson Electronics, Ltd. (RELL)
Q2 FY25 net sales increased 12.1% YoY, the second consecutive quarterly YoY increase Green Energy Solutions (GES) net sales increased 129% from Q2 FY24 Richardson Electronics ended Q2 with ...
Wall Street Journal2d
Richardson Electronics Ltd.
The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...